Total serum IgE concentration in patients with psoriasis: a case-control study

Area of Science:

• Immunology
• Dermatology

Background:

• Psoriasis is a chronic inflammatory skin condition with complex immune system involvement.
• The role of immunoglobulin E (IgE) in the pathogenesis of psoriasis remains debated.
• Previous research has yielded conflicting results regarding IgE levels in psoriasis patients.

Purpose of the Study:

• To compare serum IgE concentrations between patients with psoriasis and a healthy control group.
• To investigate the correlation between serum IgE levels and disease severity, duration, age, and gender in psoriasis patients.

Main Methods:

• A case-control study involving 58 psoriasis patients and 58 age- and sex-matched healthy controls.
• Serum IgE levels were measured using electrochemiluminescence assay.
• Disease severity was assessed using the Psoriasis Area and Severity Index (PASI).

Main Results:

• Mean serum IgE concentration was 200.06 in psoriasis patients and 115.13 in controls (P=0.16).
• Elevated serum IgE (> normal concentration) was observed in 22.4% of patients versus 17.2% of controls (P=0.48).
• No significant correlation was found between serum IgE levels and PASI score (P=0.11, r=0.21), disease duration, age, or gender.

Conclusions:

• Serum IgE concentrations are not significantly elevated in patients with psoriasis compared to healthy individuals.
• IgE levels do not correlate with the severity or duration of psoriasis.
• The findings suggest that IgE may play an insignificant role in the immune response underlying psoriasis.